Exhibitors Search
VSPharmtech Co., Ltd.
Booth no.
H50
|
Exhibition
|
|KOREA LIFE SCIENCE |
|---|---|
|
Country
|
| Korea, South |
|
Address
|
|191 Seongseo4chacheomdan-ro, Dalseo-gu, Daegu, Republic of Korea |
|
Tel
|
|+82-70-4740-7117 |
|
Exhibits
|
| Development of Apoptosis Enhancers for Synergistic Combination with DNA-Damaging Standard Therapies Without Additional Toxicity |
|
Company Type
|
| Pharmaceutical / Drug Development Company , Biotech Venture / Startup |
Exhibitor Information
VSPharmTech is a clinical-stage biotechnology company developing anticancer drugs that enhance the efficacy of radiotherapy, with the goal of transforming the paradigm of cancer treatment. The company is committed to advancing life-saving drug development and innovative medical approaches, identifying and commercializing improved standard-of-care technologies and therapies to deliver safe and effective cancer treatments in areas of high unmet medical need.
Exhibit Description
VS-101, Radiosensitizer
- Radiosensitizer is a therapeutic agent designed to enhance the efficacy of radiotherapy (RT) in cancer treatment.
- Completion of Phase I clinical trial for Head and neck cancer in Korea
- Achievement of IND approvals for Phase II clinical trial for various indications (Head and Neck cancer, Breast cancer, Glioblastoma) in the United States
- Orphan Drug Designation (ODD) for glioblastoma
- Radiosensitizer is a therapeutic agent designed to enhance the efficacy of radiotherapy (RT) in cancer treatment.
- Completion of Phase I clinical trial for Head and neck cancer in Korea
- Achievement of IND approvals for Phase II clinical trial for various indications (Head and Neck cancer, Breast cancer, Glioblastoma) in the United States
- Orphan Drug Designation (ODD) for glioblastoma
KYUNGYON EXHIBITION CORP.
